Anaptysbio (ANAB) Interest & Investment Income (2017 - 2026)

Anaptysbio has reported Interest & Investment Income for 10 years, with the latest figure at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income fell 39.88% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $11.7 million (down 40.18% YoY), and the FY2025 full-year result was $13.5 million, down 31.8% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $2.7 million, up from $2.5 million in the prior quarter.
• The five-year high for Interest & Investment Income was $5.3 million in Q3 2024, with the low at $342000.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $3.7 million across 5 years, with a median of $4.4 million in 2025.
• Annual changes were most pronounced in 2022 — Interest & Investment Income surged 5545.59% — and 2025, when it slumped 52.35%.
• Anaptysbio's Interest & Investment Income stood at $3.8 million in 2022, then rose by 27.12% to $4.9 million in 2023, then grew by 7.85% to $5.3 million in 2024, then tumbled by 52.35% to $2.5 million in 2025, then rose by 5.78% to $2.7 million in 2026.
• The last three Interest & Investment Income figures came in at $2.7 million (Q1 2026), $2.5 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.